Medicare Part D coverage · ciprofloxacin · RxCUI 309305
ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension
Per the CMS 2026 Part D formulary file, ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension is covered by 1,596 Medicare Part D plans (31.6% of enrollable products), averaging Tier 3.6, with prior authorization required on 0% of covering formularies.
- 31.6%
- Plan coverage
- 1,596
- Plans covering
- T3.6
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension
Per the CMS 2026 Part D formulary file, ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension (RxNorm concept RXCUI 309305, generic name ciprofloxacin) appears on 25 distinct formulary files spanning 1,596 Medicare Part D plan offerings - 31.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.6.
Real-world access to ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,810 Part D beneficiaries filled ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension in 2023, with total plan-and-beneficiary spending of $396,416 and an average per-beneficiary annual cost of $219.01. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension today.
Coverage Details
- Formularies covering
- 25
- Plans covering
- 1,596
- Coverage rate
- 31.6%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,810
- Total spending
- $396,416
- Avg per beneficiary
- $219.01
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T4 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension
98 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Savings (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Freedom Medi-Medi Partial (HMO D-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Medi-Medi Full (HMO D-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Optimum Emerald Partial (HMO D-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Emerald Full (HMO D-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Freedom Medicare Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Medicare Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Savings COPD (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Savings COPD (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Máximo (HMO-POS) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Máximo (HMO-POS) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Optimum Gold Rewards Plan (HMO) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Platinum Plan (HMO) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Gold Plan (HMO) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Gold Rewards Plan (HMO) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
Showing top 50 of 98 plans.
Frequently Asked Questions
Is ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension covered by Medicare Part D?
Yes, ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension is covered by 1,596 Medicare Part D plans (31.6% of all Part D formularies).
What tier is ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension on Medicare Part D plans?
ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension averages Tier 3.6 across Part D plans, ranging from Tier 1 to Tier 4.
Does ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension require prior authorization?
0% of Part D formularies require prior authorization for ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension?
In 2023, total Medicare Part D spending on ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension was $396,416, covering 1,810 beneficiaries. The average spend per beneficiary was $219.01.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.